Brazil gears up for embryonic R&D "production"
This article was originally published in Clinica
Brazil is a step closer to activating its national embryo "production" system (SisEmbrio), paving the way for an ambitious programme of cell and tissue regeneration R&D (see Clinica No 1307, p 12). A survey of the country's cell and regenerative tissue banks (BCTGs) and its 120 or so assisted reproduction clinics, conducted to establish the number of supernumerary embryos available nationally for such research, concluded last week. These facilities will now be obliged to provide such information on an annual basis. The data will be used by SisEmbrio to, among other things, determine how many embryos are available for research use at any given time. Brazil's bioethics legislation (which was recently passed following a three-year judicial review) allows embryonic stem cell R&D provided that only supernumerary embryos that have been stored for at least three years, or new embryos defined as unviable, are used.